Searched for
COVISHIELD ASTRAZENECA VACCINE
Good shot, bad shot: What you need to know about Covishield issueCovishield Side Effects: Controversies surrounding vaccine side-effects persist despite Covid-19 waning. Covishield, developed by AstraZene...- Covishield Side Effects: What's TTS syndrome, symptoms, and danger signs you shouldn't ignoreCovishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS...
- Bollywood celebs express concern over Covishield vaccine's side effects: What they saidAstraZeneca's recent disclosure about Covishield's rare but serious side effects has sparked concerns among both medical professionals and ...
- Covishield Vaccine Case: AstraZeneca expresses 'sympathy' for those who lost loved onesCovishield Vaccine Row: Following AstraZeneca's acknowledgment of a rare side effect associated with its COVID-19 vaccine, known as Covishi...
- Covishield vaccine: Plea filed in SC seeking formation of expert panel to study side-effects, risk factorsA petition filed in the Supreme Court seeks the formation of a medical panel from AIIMS, Delhi to study Covishield's side effects. It deman...
- AstraZeneca acknowledges its covid vaccine, Covishield, can lead to rare blood clot side effects; Here's what we knowCovishield Covid Vaccine: The Covishield COVID-19 vaccine, developed by AstraZeneca in partnership with the University of Oxford, has been ...
- RDIF says early results of 'mix & match' of Sputnik Light, AstraZeneca jab found to be safeAstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.
- SII gets nod to send Covid vaccines to Nepal, Bangaldesh, Myanmar, bulk to AstraZeneca; Bharat Biotech to IranUnion Health Minister Mansukh Mandaviya on September 20 announced that India will resume export of surplus COVID-19 vaccines in the fourth ...
- UK govt revises advisory, approves Covishield as qualified vaccine for travelIndia had earlier protested the UK's non-recognition of the Covishield vaccine and warned of “reciprocal measures” if the ‘discriminatory p...
- Bharat Biotech's Suchitra Ella says vaccines shouldn't be a barrier to enter any nation if approved by national regulatory authoritiesIndia has not been able to make it in the list of countries whose vaccinations will be accepted in the UK from next month. The UK has said ...
- SII won't seek special marketing nod from EU body for vaxUK drug company, AstraZeneca, which developed the vaccine with Oxford University, has asked the regulator European Medicine Agency (EMA) to...
- Covishield single-dose efficacy drops after 16 weeks in those above 60 years of age: Sri Lankan researchSri Lanka is still waiting to vaccinate over 500,000 people with the second jab of Covishield. They were the first recipients of the vaccin...
- AstraZeneca wants Serum Institute of India listed as manufacturing site“We have requested the addition of Serum Institute of India as an alternative manufacturing site on the Vaxzevria licence,” an AstraZeneca ...
- No application for Covishield yet: EU drug regulatorThe EMA website lists four vaccines as under rolling review — Sputnik V, Covovax, CureVac and Sinovac. An SII executive who is familiar wit...
- Serum Institute seeks 'Green Pass' approval for Covishield, applies to European agencyResponding to queries from ET, an EMA spokesperson confirmed on Monday that Covishield does not have marketing authorisation. "Even though ...
- Approval to Covishield would be considered should we receive marketing authorisation application: EU agencyThe EU Digital COVID certificate or 'Green Pass' will be mandatory to travel to European countries and the document is likely to serve as p...
- India extends shelf life of AstraZeneca vaccine: SourceThe approval, given to a licensed version of the drug made by the SII and exported to dozens of countries, could help health authorities mi...
- SII seeks Government's nod to give 50 lakh Covishield doses to UK, says won't affect India's vaccination driveIn a communique to Union Health Secretary Rajesh Bhushan on Tuesday, the Director of Government and Regulatory Affairs at the Pune-based Se...
- WHO gives nod to AstraZeneca vaccine and its 'tremendous potential'"The AstraZeneca COVID-19 vaccine (including Covishield) continues to have a positive benefit-risk profile, with tremendous potential to pr...
- DCGI may await UK nod for AstraZeneca's Covid shot before approving SII vaccineOfficials said both the Pfizer and the SII emergency use applications are being reviewed on an accelerated basis. But as the trials for Ser...
Load More
